Type 2 Diabetes; Once-weekly exenatide injection improves blood sugar control more than daily oral s...
Type 2 Diabetes; Once-weekly exenatide injection improves blood sugar control more than daily oral sitagliptin or pioglitazone and induces more weight loss DURATION-2 study
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
491 patients received at least one dose of the study drug and were included in the final analysis (160 exenatide, 166 sitagliptin, 165 pioglitazone). Treatment with exenatide reduced HbA1c by 1*5%, compared with 0*9% in the sitagliptin group and 1*2% in the pioglitazone group. Patients in the exenatide group lost on average 2*3kg, compared with a m...
Alternative Titles
Full title
Type 2 Diabetes; Once-weekly exenatide injection improves blood sugar control more than daily oral sitagliptin or pioglitazone and induces more weight loss DURATION-2 study
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_580115369
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_580115369
Other Identifiers
ISSN
1531-6386
E-ISSN
1532-4664
